Last reviewed · How we verify
NCT07478445: RECADO
Home Rehabilitation After Hip Fracture
trial in Hip Fractures (ICD-10 72.01-72.2) in 80 participants. Completed in 30 September 2025.
26 February 2025
Quick facts
| Lead sponsor | Instituto de Investigacion Sanitaria La Fe |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 February 2024 |
| Primary completion | 26 February 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 1 location across Spain |
Conditions studied
- Hip Fractures (ICD-10 72.01-72.2) — all drugs for Hip Fractures (ICD-10 72.01-72.2) →
- Home Care, Hospital-Based — all drugs for Home Care, Hospital-Based →
- Home Care Services — all drugs for Home Care Services →
Sponsor
Instituto de Investigacion Sanitaria La Fe — full company profile →
Who can join
65 and older, any sex, with Hip Fractures (ICD-10 72.01-72.2) or Home Care, Hospital-Based. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine whether a home-based rehabilitation program can help older adults recover after surgery for a hip fracture. The program is delivered by a specialized "Hospital-at-Home" unit, which provides hospital-level care in the patient's home. Participants in this study are adults aged 65 years and older who have undergone hip fracture surgery at Hospital Universitari i Politècnic La Fe in Valencia, Spain. Instead of remaining in the hospital after surgery, participants will be admitted to the Hospital-at-Home program. A multidisciplinary medical team will provide comprehensive care at home, including medication management, wound care, and in-home physical therapy. The primary goal of the study is to assess recovery of walking ability and mobility within the home. The study will also evaluate overall functional improvement, frailty, and survival. Participants will be assessed at the start of the program and again at 45 days and 180 days after surgery. The information collected will help determine whether this type of home-based care is an effective option for supporting recovery and independence in older adults after a hip fracture. Recruitment for the study began in February 2024 and is expected to continue for one year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07478445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Fractures (ICD-10 72.01-72.2)
Currently open trials in the same condition.
- NCT06678529 — Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients · NA · recruiting
- NCT07189260 — Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia · NA · recruiting
Other Instituto de Investigacion Sanitaria La Fe trials
Trials by the same sponsor.
- NCT07402083 — Administration of Extracellular Vesicles From Donor Human Milk in Preterm Infants · recruiting
- NCT07238608 — Impact of UFPs and MNPs on Fetal Health · recruiting
- NCT06950996 — A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and · completed
- NCT06866769 — Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR · recruiting
- NCT05942209 — ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07478445 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigacion Sanitaria La Fe
- Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07478445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing